Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 03, 2013

AbbVie Inc. v. Roxane Laboratories Inc.

Track this case

Case Number:

2:13-cv-00645

Court:

Ohio Southern

Nature of Suit:

Patent

Judge:

Michael H. Watson

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 06, 2014

    Roxane Seeks To Nix 'Improperly Issued' AbbVie HIV Patent

    Roxane Laboratories Inc. sued the U.S. Patent and Trademark Office last week, asking a federal judge to rule that an AbbVie Inc. HIV drug patent Roxane is accused of infringing is invalid because it was improperly issued by the patent office.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login